Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression

Clinical trial NCT02178683 · UNKNOWN

Trial details

NCT number: NCT02178683
Sponsor: Colorado Blood Cancer Institute
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Graft Versus Host Disease

Start date: 2010-11-01
Primary completion: 2016-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.